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INTRODUCTION 
Cardiac surgery has grown up with regard to technical 
advances..and major cardiac  anomalies are repaired ,majorly aided and 
eased with the advent of cardio pulmonary by pass… 
Extra corporeal circulation has made it extremely safe, in providing 
perfusion to the heart, rendering the heart more accessible and amenable 
for complicated procedures. 
But the use of cardio pulmonary by pass has not been free from 
adverse effects …there is a hoard of changes that happen at the bio 
molecular lever which triggers off, a whole body inflammatory 
response… 
The commonest function to be hampered is easily the physiology 
of circulation.  There is significant amount of disruption in the normal 
coagulation system ,leading to trivial to significant blood loss.. 
The reason for this altercation would be in multitude, and to name 
a few… 
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 Fall in the quantity of platelets 
 Decrease in the factors that aid in clotting 
All this is possibly due to hem dilution… 
Contact with the external circuit is another possible factor that can 
add to the woes. 
After receiving the patient in post operative room, if there is 
significant or obscene bleeding, it possibly is due to a surgical 
cause,whereas if there is a steady rise in drains with no sudden 
hemodynamic instability associated with deranged clotting time,bleeding 
time or platelet levels, then it could be termed as medical bleed… 
Medical bleeding, once it has been ascertained,can be rectified by 
various measures....compensating the loss with blood and blood products, 
protamine to neutralize heparin and administration of  anti fibrinolytics 
like tranexamic acid.. 
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The usage of blood and products is not safe in entirety,and can 
cause a mixture of problems adding on to the woes of the patient and the 
managing surgeon… 
The efficiency of tranexamic acid in controlling post operative has 
been elaborately studied and various dosing regimens have been 
suggested… but there is no fixed dosing till date..in cardiac surgery.. 
We decided  to fix up a dosage ,and check for the efficacy of this 
drug in reducing the immediate  medical bleed in patients undergoing  
cardiac  surgery  in  Rajiv Gandhi government general hospital. 
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AIM OF THE STUDY 
The study was designed with the primary AIM of evaluating  the  
effect of tranexamic  acid in reducing the bleeding tendency in immediate 
post operative period for patients who have  undergone cardiac sugery . 
To evaluate whether tranexamic acid reduces the need for red cell 
transfusions. To understand the occurrence of post operative thrombo  
embolic events. 
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REVIEW OF LITERATURE 
The advent of cardio pulmonary by pass has made cardiac surgery 
a relatively safer modality. The history of it’s evolution  is too elaborate 
and no one person could solely be identified for the clinical use. 
John gibbon is one of the big names in pioneering cardio 
pulmonary by pass. In late 1930 s he was instrumental in advancing the 
application of that thought to clinical use. 
Inspite of lack of support, his perseverance finally reaped benefits 
and he did his first successful cardiac surgery on CPB in 1953..since then 
CPB has evolved and come a long way in aiding cardiac surgery. 
The other big names would be Dennis , Richard varco, Viking 
bjork, C.Walton lillehei and John kirklin..   The use of CPB coupled with 
oxygenator was first used in 1955, march 22 at mayo hospital, ant the 
surgery was repair of a ventriculo septal defect. 
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FEATURES OF CARDIO PULMONARY BY PASS 
The  systemic venous return to the heart is diverted to the pump 
oxygenator, and then returned via arterial lines to the systemic arterial 
circulation.. this artificial state of maintaining perfusion incites lot of  
physiologic process…a few to mention would be.. 
Humoral and cellular components of defense and inflammatory 
responses are usually altered. 
The pressure gradients in systemic and pulmonary venous and 
arterial systems are manipulated. 
Another  system would be that of the physiology of coagulation 
cascade…that seems to take the brunt of all..with derangements in 
platelet  functions ,decrease in clotting factors ,fall in haematocrit. 
There are multiple other molecular level changes, oxygen 
consumption,  mixed venous oxygen saturation, lactic acidosis ,regional 
and end organ tissue perfusion. 
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Just  before  establishing   cardiopulmonary by  pass , the patient is 
anticoagulated  generally   to avoid   thrombosis complicating  the  
circuit.  
The anticoagulant that is commonly used is HEPARIN, usually 
given at a dose of three to four milligram per kilogram of body weight. It 
belongs to a group of low molecular weight glycosaminoglycans and has  
a molecular weight ranging from Three thousand to ten thousand .  
The mechanism of action is by producing a antithrombin 3 a  like 
effect..and heparin is usually neutralized with protamine sulphate. 
How ever there could be significant post operative medical bleed 
because of  heparin re bound, which is attributed to either re circulation of 
heparin from tissue bound stores,or because of dissociation of heparin 
protamine complexes or because of shorter protamine half life time or 
may be a combination of all these factors. 
Platelet activation  during CPB has always been extensively 
studied and been attributed to be a major reason in causing post operative 
bleed. 
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It has been shown in vitro studies that there is quantitative decrease 
in platelet strength. There is a decrease of platelets by about sixty percent 
within two minutes of commencing CPB and a significant reduction by 
eighty percent within eight minutes of CPB and can remain so for about 
twenty four hours. 
Platelet aggregates have been visualized in retinal arterioles even 
days after CPB..Platelet functions usually reverses to normalcy  within 
three days after CPB. 
Membrane oxygenator seems to be playing a crucial role in 
affecting the platelet functions.  Oxygenators made of silicon rubber 
causes  lesser  platelet damage  than bubble oxygenators. 
Aprotinin  has been proven to have reduce the platelet 
abnormalities, but has lost it’s  popularity in view of safety concerns. 
Activation  of coagulation cascade  seems to be an important 
concern in going on CPB ,cause if the patient were not to be heparinised  
then almost immediately the respose would be massive thrombo 
embolism leading to pump failure,  such  would be the response of the 
activation.. 
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This kind of  activation is triggered by direct CONTACT,  
INTRINSIC  and EXTRINSIC mechanism . This response is blunted by 
heparinising  the patient.   And even after heparinising ,there could be 
some amount of activation and fibrin formation,which has been attributed 
to post operative bleeding. This is possibly because most of the soluble 
clotting factors are reduced in quantity by the end of  CPB. 
It has been presumed that one of the important reasons for post 
operative  bleeding  was platelet dysfunction, recent studies have shown 
that activation of fibrinolytic  cascade is also an added factor. Normally 
present in active plasminogen is converted to plasmin to cause 
degradation of fibrin products. The  effect of plasmin on bleeding is 
proved by  the fact that use of aprotinin reduces post operative bleeding. 
Aprotinin is a plasminogen inhibitor. 
Hypothermia  is another factor that could possibly aggravate post 
operative bleeding by causing platelet dysfunction.Thus it is important to 
have adequate  rewarming on CPB. The use of platelet transfusion has 
been helpful. 
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 Even the increased circulation of catecholamines can cause platlet 
dysfunction. The clot remodellin properties are reduced on activation of  
fibrinolytic cascade. 
The response to CPB on coagulation cascade ,depends and varies 
from individual people..some blunted ,  some extremely sensitive to even 
minor stimuli. 
Post operative bleeding  usually is a major concern and might 
warrant re operation to avoid cardiac tamponade.  Recognition  of  the 
cause of bleeding is crucial. Surgical causes is ruled out.Increasing drains  
with evidence of tamponade , points to a surgical cause usually.  
Medical bleed is usually lesser but regular and can be predicted 
with associated abnormalities in bleeding time and clotting time  and 
reverted with pharmacological support. 
The   etiology  in post operative bleeding can listed as…. 
 Increased lysis of fibrin. 
 Heparin overdosing. 
 Protamine excess 
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 Decrease in clotting factors. 
 Fragile clots vulnerable for fragmentation. 
 Reduced platelet counts. 
 Drug induced thrombocytopenia. 
 In appropriate response of aggregation to mediators. 
 Selective decrease in younger platelets. 
 Fragmenting platelets. 
 Plasmin mediated platelet dysfunction. 
 Impaired clot re modeling mechanism. 
 Haematological  factors involved in CPB 
 Kallikrein 
 High molecular weight kallikrein 
 Thrombin 
 Plasminogen to plasmin 
 Thrombexane two 
 Serotonin 
 Oxygen free radicals 
 Tissue plasminogen activator 
 Cytokines 
 Complement 3a ,  
 Complement  5a, 
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 Complement 5b-9. 
 Adenosine diphosphate. 
 The clinching of medical bleeding in post operative scenario is 
greatly facilitated with coagulation testing. 
 The  set up is complete with a centralized coagulation  testing. 
 The few commonly done tests are.. 
 Prothrombin time. 
 Activated partial thromboplastin time. 
 Clotting time 
 d-Dimer 
 Fibrin degradation products 
 Platelet count 
 Platelet  aggregometry 
 Ecarin  clotting time 
Prothrombin time ..a test wherein it involves  incubated 
plasma,where the calcium is complexed previously with citrate ,so as to 
prevent activation of coagulation. 
The incubated plasma is treated with thromboplastin,and since it 
comes with it’s own phospholipid and tissue factor , the sample if it 
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contains adequate  factor seven and factors   involved in common 
pathway, the sample will gel faster in about twelve seconds. 
The international normalized  ratio allows  comparison of 
prothrombin  time with different  commercial reagents. 
 
The principle of    aPTT  is incubation of the plasma sample with 
thromboplastin without the tissue extract , so it has to clot with surface 
activation only. There are a lot of surface  activation agents like silica, 
kaolin celite..etc… 
Heparin usually alters aptt  , but in large doses can alter 
prothrombin time. 
The coagulation tests are usually done bedside or wherever the 
results can be available sooner so as to increase the rapidity with which a 
diagnosis can be made, because timely intervention is crucial in cardiac 
surgery. 
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Prompt intervention often saves lives. 
There are lot of products available to enhance prompt lab 
evaluation with  a drop of blood,they   all  work on different principles  
like magnetic rotation that ceases, optical interference  ,electro 
mechanical disruption  and  clot formation with retraction. 
Hypothermia ,hemo dilution,   decreased platelet count  and 
protamine excess can all derange or increase activated thromboplastin 
time. 
Hence it is vital to adequately rewarm on CPB ,monitor heparin 
levels, titrate protamine appropriately only.hemodilution  can be avoided 
with priming volume additives. 
Even the best of precautions ,can never render a hassle free post 
operative period. Un explained bleeding remains one of the entity of  
what is termed as  RESPONSE VARIABLES. 
Recent advances in testing,  advances in  molecular biology, 
technical progress have all given us an excellent armamatorium in 
fighting cardiac diseases. 
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The pharmacological assistance has benefited innumerably. 
The common drugs that have been deployed in combating post 
operative bleeding are.. 
Aprotonin  
 Aminocaproic acid 
 Protamine  
 Tranexamic acid 
 Vitamin k 
Aminocaproic acid and tranexamic acid belong to the group of 
lysine analogs. The mechanism of action is that these drugs competitively  
binds to lysine  binding   sites  of  plasminogen/plasmin  and thus 
prevents de gradation of fibrin or fibrinogen. 
Tranexamic acid is a water soluble lysine analog..onset of action 
rapid by intravenous route. The biological half life is two to three hours 
and the drug is totally cleared by renal route..nearly  60% of the drug is 
excreted by renal system at three to four hours and about 90% in about 
twenty four hours. 
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There has varied dosing protocols and regimens. No specific 
benefit pattern fixed as of now. One popular  trial  had tranexamic acid 
given in doses of 10 to 15 milligram per kilogram of body weight. 
The adverse effects of tranexamic acid are lesser morbid and organ 
toxicity has rarely happened. Use of tranexamic acid has considerably 
reduced post operative bleed in patients known to have a higher 
propensity of bleeding. 
Based on the scenarios, the benefit varies.patients having long 
pump runs, lower haematocrit, body weight less than forty kilograms 
would benefit more with tranexamic acid. 
Chemical formula of tranexamic acid. 
 
Trans 4 –cyclohexane carboxylic acid. 
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MATERIAL AND  METHODS 
This  study, designed to be prospective and randomized was 
undertaken as an observational  evaluation    on the topic of usefulness of 
tranexamic acid in reducing post operative bleed in patients undergoing 
cardiac surgery. 
This  study was conducted in the department of cardio thoracic 
surgery  at Rajiv Gandhi government general hospital, Chennai. 
This study design was for a year , 2013,  and we used a descriptive 
analytical method. 
 INCLUSION CRITERIA 
All patients undergoing  open cardiac surgery procedures involving  
cardiopulmonary  by pass. 
EXCLUSION CRITERIA 
 Patients with pre existing evidence of of coagulopathy. 
 Patients with hepatic  dysfunction 
 Patients with renal dysfunction 
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 Off  pump cardiac sugery cases 
METHODOLOGY 
Relevant information were documented in a specially designed 
proforma. 
Meticulous   clinical examination preceded by detailed history, 
using pre framed questions. 
Sixty patients  undergoing cardiac  surgeries were randomized into  
a group of two,  thirty each.  One group of thirty patients would receive  
tranexamic acid  , loading dose  of  15 milligram per kilogram of body 
weight , five minutes before skin incision and one more similar dose after 
weaning from CPB. The other group would not receive tranexamic acid. 
Assessment of efficacy obtained by evaluating post operative data. 
Patients were received in post operative room and monitored. 
Routine blood investigations sent on arrival..chest drains were 
documented one hourly.clinical evidence for generalized medical bleed 
looked out for.red cell transfusion decided on appropriate indications 
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only.all this data was recorded and analysis drawn and conclusions  
made. 
The patients were followed up during their hospital stay to record 
any events of thrombo embolism. 
Ethical committee clearance was obtained  and all procedures were 
performed without any ethical breach.  The patient and their relatives 
were kept well informed about the procedure. 
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Drain trend in tranexamic group.  Expressed in milliliter  over first 
six hours. 
 
  
0
50
100
150
200
250
300
350
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30
35 
 
 
Post op drain…mean 120 ml over six hours..std deviation…5.781. 
P – value......0.256 
Drain trend in neutral group…blood loss expressed in millilitre for 
the first six hours. 
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Post op drain at six hours..average..250 ml..std deviation..5.931 
P – value   0.421.. 
Packed cell transfusion in tranexamic acid group. 
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The blue area represents the fraction of patients who received one 
unit of packed cells…..40% 
The other fraction represents the percentage of people who did not 
receive transfusion……60% 
Packed cell transfusion in neutral group. 
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 The marroon represents 40% who received one unit of packed cell. 
 The blue represents the 35% who received two units of packed cell. 
 The green represents 20% who received three units of packed cells. 
 The purple represents 5% who did not receive transfusion. 
 Platelet count in tranexamic acid group in immediate post op. 
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Y axis is in percentage of the patients. 
Mean 1.25 lakhs.  std deviation….6.338  
P value ….0.587 
Platelets in immediate post op…in both groups. 
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The darker colour illustration is the tranexamic acid group, and the 
lighter colour represents the neutral group. 
Mean ..1.1 lakh.. std deviation..20.57  .p value..6.840 
Clotting time in tranexamic acid group. 
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DISCUSSION 
This study was designed as a prospective and randomized study.    
This  study was carried out in the department of cardiothoracic surgery, 
Rajiv Gandhi government general hospital in the year 2013. 
The study included  sixty patients undergoing  cardiac surgeries in 
our department..they were randomized into a group of two, one group of 
patients received tranexamic acid at a dose of fifteen mg per kg body 
weight of the patient…one loading dosefive min before skin incision and 
one on weaning patient fom  CPB..the other group did not recieve 
tranexamic acid. 
The patients were operated by single team of doctors, follow up 
charted meticulously,recorded data converted into analytical data with the 
help of a statistician. 
The patients had their routine follow up..no intervention was made 
specially. Clinical signs for medical bleed was carefully monitored. Drain 
levels documented.transfusions of packed cell decided based on 
haematocrit. There was no patient in either group who had to been  re   
operated. 
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The drain trends were definitely higher in the group that did not 
receive tranexamic acid…this group was always referred to as the neutral 
group. 
The patients had their routine blood investigations  done  at 
immediate post operative period.the neutral group did not receive any 
tranexamic acid at induction nor on weaning on CPB. 
The beneficial effects were obvious with tranexamic acid group in 
the immediate post op. 
The age distribution was almost similar to both groups..the young 
adult population seemed to dominate in both groups,underlining the 
higher incidence of  rheumatic heart disease in that group. 
The younger adult population makin upto fifty percent in 
tranexamic group and forty five percent in neutral group. And among the 
distribution of the pathology of heart diseases,mitral valve replacement 
was on top in both groups with 52% in tranexamic acid group and 42 % 
in neutral group,  and CABG was more in neutral group,  24%. 
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The drain levels in tranexamic acid was an average of 100 ml over 
first six hours  as compared to 250 ml of neutral group,the difference is 
striking,although the p value is not significant, the trend definitely points 
to the use of tranexamic acid in reducing post operative bleed. 
The drain levels at twelve hours of post op period in both the 
groups are not too different,with an average of 100 ml and 150 ml in 
tranexamic and neutral group respectively.  The drain levels at twent four 
hours remained almost similar ,averaging 50 and  100 ml respectively.  
The  benefits of tranexamic acid in reducing post operative bleed is 
obvious, yet the benefits after twent four hours were not  very obvious. 
The drain levels there after were not taken into account, but no 
patient in either group had any alarming bleed. 
The coagulation tests done on either group showed mild beneficial 
trends towards tranexamic acid. 
There was a minimal difference in clotting time, with both groups 
having 65 to 68% of patients with normal clotting time. And so was the 
results with the platelet counts with no gross disparity between the 
groups. 
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The need for packed cell transfusion was only one unit in 45% and 
the remainder was not transfused in tranexamic acid group. 
About 40% were transfused with one unit ,35% with two units, 
20% with three units in the neutral group. 
This reflects the obvious trend of increased need of red cell 
transfusion in the neutral group. 
The platelet transfusions were given at eight hours or later only if 
there was a rebound bleed. 
About four units transfused ,if required.there was no difference in 
platelets that was transfused, between the groups. 
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RESULTS 
The observation and the analytical data from this prospective 
,randomized study yielded  the following  results. 
  In this study, either groups had a  preponderance of young adult 
population. The age group of 25 to 36 were about  50% and 45% in 
tranexamic and  neutral group. 
 
  Mitral valve replacement was among the highest in both groups with 
close to 50 and 42% in tranexamic and neutral group. 
 
 The mean post operative drain at six hours were 120 ml and 250 ml in 
tranexamic acid and neutral group, higher drain tendencies were 
reported in the neutral group.th p value was 0.27 not very significant, 
yet the trend reflects in favour of tranexamic acid. 
 
 The need for red cell transfusion or packed cells were, only 45% 
required one unit of packed cell, in tranexamic acid group. 
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 The need for packed cell transfusion in neutral group was like, 40% 
required one unit, 35% required two units, and 20% required three and 
more, with 5% not requiring transfusion.. 
\ 
 The clotting time tests were almost similar with not much of disparity, 
but a smaller trend of benefit in tranexamic acid group, which had 
20% of prolonged  clotting time, six  percent lesser than the 
tranexamic acid group. 
 
 The platelet counts too, showed a benefit trend towards tranexamic 
acid group.th p value was not significant though, with 0.587 
 
 There were three mortality in each group, totaling six..and all the 
mortality were not related to the drug..the cause of death was low 
cardiac out put syndrome. 
 
 There were no incidence of  re operation due to bleeding in either 
groups. 
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CONCLUSION 
 In this study , we come to the conclusion that using tranexamic acid 
reduces immediate post operative bleeding and significantly reduces 
the morbitity of the patient. However there is not much benefit in post 
operative period beyond twenty four hours. 
 
 The need for packed cell transfusion also is significantly  lesser with 
the tranexamic acid group. 
 
 The abnormalities in clotting time and and platelets were almost 
similar with no statistical significance in either group,but showing 
marginal beneficial trend in tranexamic acid group. 
 
 Tranexamic acid has been an efficient , cost effective and simple way 
in controlling post operative bleed in patients undergoing cardiac 
surgery. 
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ANNEXURE   ONE 
 ABBREVIATIONS 
 ASD--- ATRIAL SEPTAL DEFECT 
 MVR—MITRAL VALVE REPLACEMENT 
 AVR—AORTIC VALVE REPLACEMENT 
 DVR---DOUBLE VALVE REPLACEMENT 
 CABG-CORONARY BYPASS GRAFT BYPASS SURGERY 
 TX GROUP- TRANEXAMIC ACID GROUP 
 RHD—RHEUMATIC HEART DISEASE 
 AS----AORTIC STENOSIS 
 MS ---MITRAL STENOSIS 
 CT—CLOTTING TIME 
 PL—PLATELET COUNT 
 Aptt—ACTIVATED PARTIAL THROMBO PLASTIN TIME 
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ANNEXURE   TWO 
PROFORMA FOR THE DATA COLLECTION FROM EACH 
PATIENT 
NAME            : 
AGE              : 
SEX               : 
IP NO            : 
DOA              : 
DOS              :  
DIAGNOSIS         : 
SURGERY           :  
PRE OP INVESTIGATIONS : 
POST OP INVESTIGATIONS : 
TOTAL CPB TIME      : 
TOTAL CROSS CLAMP   : 
NO OF C P           : 
BLOOD LOSS(DRAINS) AT 6 HOURS POST OP : 
DRAINSAT 12 HOURS POST OP : 
AT 24 HOURS POST OP : 
NEED FOR RED CELL TRANSFUSIONS(NO)    : 
OTHER BLOOD PRODUCTS USED           : 
THROMBOEMBOLIC EVENTS IF ANY          : 
POST OP COMPLICATIONS IF ANY            : 
 
DATE  :                                                               Signature of investigator 
PLACE : 
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ANNEXURE   THREE 
 
Bµõ#a] uPÁÀ uõÒ 
 
 
C¸u¯ AÖøÁ ]QaøŒ öŒ#²® @£õx C¸u¯zvß C¯UP® {Özu¨£mkAuß µzu 
Kmh•® uøhöŒ#¯¨£kQÓx. A¢u Œ©¯zvÀC¸u¯zøu £õxPõUP ]» ÁÈ 
•øÓPÒ EÒÍÚ. AÖøÁ ]QaøŒUS¨¤ß £»¸US Cµzu® EøÓ²® ußø© 
SøÓ¢xCµzu® @Œu©øhQÓx. C¢u B#Âß@£õxCøuSøÓ¨£uØSiµÚUŒªU 
B]mGßÝ® ©¸¢x E£@¯õQUP¨£k®. 
 
}[PÒ C¢uBµõ#a]°À £[@PØP |õ[PÒ Â¸®¦Q@Óõ®.  AuÚõÀ 
@|õ°ßB#ÁÔUøP@¯õAÀ»x ]QaøŒ@¯õ £õv¨¦US HØ£hõx Gß£øu²® 
öu›ÂzxUöPõÒQ@Óõ®. 
 
•iÄPøÍ AÀ»x P¸zxUPøÍ öÁÎ°k® ö£õÊ@uõ AÀ»x Bµõ#a]°ß ö£õÊ@uõ 
u[PÍx ö£¯øµ@¯õ AÀ»x Aøh¯õÍ[PøÍ@¯õ öÁÎ°h©õm@hõ® Gß£øu²® 
öu›ÂzxU öPÒQ@Óõ®. 
 
C¢uBµõ#a]°À £[@PØ£x u[PÐøh¯ Â¸¨£zvß @£›À uõß C¸UQÓx. @©¾® 
}[PÒ G¢@|µ•® C¢u Bµõ#a]°À C¸¢x ¤ßÁõ[P»õ® Gß£øu²® 
öu›ÂzxUöPõÒQ@Óõ®. 
 
C¢u £›@ŒõuøÚ°ß •iÄPøÍ Bµõ#a]°ß @£õx AÀ»x Bµõ#a]ß •iÂß@£õx 
u[PÐUS AÔÂ¨@£õ® Gß£øu²® öu›ÂzxU öPõÒQ@Óõ®. 
 
Bµõ#a]¯õÍº øPö¯õ¨£®   £[@PØ£õÍº øPö¯õ¨£® 
 
@uv :  
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ANNEXURE   FOUR 
Bµõ#a] J¨¦uÀPiu® 
 
Bµõ#a] uø»¨¦  :  ""C¸u¯ AÖøÁ ]QaøŒUS¨¤ß HØ£k® Cµzu® CÇ¨ø£ 
SøÓUPEuÄ® iµÚUŒªU B]m''. 
 
ö£¯º    :   @uv    : 
Á¯x    :   EÒ@|õ¯õÎGs  : 
£õÀ    :   Bµõ#a] @ŒºUøP Gs. : 
B#Ä öŒ#²®  
{ÖÁÚzvß ö£¯º : öŒßøÚ ©¸zxÁUPÀ¿› 
 
C¢uBµõ#a]°ß ÂÁµ[PÐ® @|õUP[PÐ® •Êø©¯õP GÚUS öuÎÁõP 
ÂÍUP¨£mhx. 
 
GÚUS ÂÍUP¨£mhÂå¯[PøÍ |õß ¦›¢x öPõsk |õßGÚx 
Œ®©uzøuöu›ÂUQ@Óß. 
 
C¢uBµõ#a]°À ¤Ó›ß {º£¢uªßÔGßöŒõ¢u Â¸¨£zvß @£›À uõß £[S 
ö£ÖQ@Óß ©ØÖ® |õßC¢u Bµõ#aŒ°¼¸¢x G¢@|µ•® ¤ßÁõ[P»õ® 
Gß£øu²® AuÚõÀG¢u £õv¨¦® HØ£hõx Gß£øu²® |õß ¦›¢x öPõs@hß. 
 
|õßC¢uBµõ#a] SÔzuuPÁÀuõøÍö£ØÖUöPõs@hß. 
 
|õßGßÝøh¯ ”¯ {øÚÄhß ©ØÖ® •Ê ”u¢vµzxhßC¢u ©¸zxÁBµõ#a]°À 
GßøÚ @ŒºzxöPõÒÍ Œ®©vUQ@Óß. 
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GßÝøh¯ µzu £›@ŒõuøÚ •iÄPøÍBµõ#a] öŒ#xöPõÒÍ Œ®©vUQ@Óß. 
 
C¢u £›@ŒõuøÚ°ÚõÀ GÚUS G¢uÂu©õÚ £UP ÂøÍÄP@ÍõAÀ»x ¤ß 
ÂøÍÄP@ÍõHØ£hõx Gß£øu²® ©¸zxÁº ‰»® öu›¢x öPõs@hß. 
 
 
Bµõ#a]¯õÍº øPö¯õ¨£®   £[@PØ£õÍº øPö¯õ¨£® 
 
@uv : 
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ANNEXURE FIVE 
Sl.No. Name 
Age/ 
Sex 
IP 
No. Diagnosis Surgery 
Total  
CPB Time 
No of 
CP 
Total Cross 
Clamp Time 
Pre of OP 
platelet,  
CT, BT 
Post of 
Blood 
Loss 
6 
Hrs 
12 
Hrs 
24 
Hrs 
PC 
Transfusion 
Thromboembolic 
Events 
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